Passive enhancement strategies in topical and transdermal drug delivery
- PMID:10425346
- DOI: 10.1016/s0378-5173(99)00095-2
Passive enhancement strategies in topical and transdermal drug delivery
Abstract
The skin has an extremely good barrier function and to improve topical bioavailability it is usually necessary to employ enhancement strategies. Optimization of the applied formulation can improve release to the skin and the use of supersaturation achieves this objective. However, supersaturated states are inherently unstable. High solvent concentrations in the formulation may remove skin lipids reducing the barrier function of the stratum corneum. Alternatively formulation components can diffuse into the barrier function where they can have two distinct effects. They may intercalate into the structured lipids of the bilayer, decreasing their diffusional resistance. Alternatively they can modify the solubility parameter of the skin lipids; the diffusing drug may then have an enhanced solubility in the skin. If the two effects can be combined synergy is observed. Deeper permeation of solvent into the viable tissue may also result in increased drug concentrations in this layer of the epidermis. The viable layer is metabolically very active and perturbation of the enzyme systems responsible for the formation of the stratum corneum lipids can reduce the barrier function. Finally a diffusing drug will encounter the blood supply. If vasoactive drugs modulate the blood flow rate, absorption can be influenced.
Copyright.
Similar articles
- Permeation enhancers compatible with transdermal drug delivery systems. Part I: selection and formulation considerations.Pfister WR, Hsieh DS.Pfister WR, et al.Med Device Technol. 1990 Sep-Oct;1(5):48-55.Med Device Technol. 1990.PMID:10171148Review.
- Transdermal drug delivery: penetration enhancement techniques.Benson HA.Benson HA.Curr Drug Deliv. 2005 Jan;2(1):23-33. doi: 10.2174/1567201052772915.Curr Drug Deliv. 2005.PMID:16305405Review.
- Permeation enhancers compatible with transdermal drug delivery systems: part II: system design considerations.Pfister WR, Hsieh DS.Pfister WR, et al.Med Device Technol. 1990 Nov-Dec;1(6):28-33.Med Device Technol. 1990.PMID:10171149Review.
- Natural products as potential drug permeation enhancer in transdermal drug delivery system.Patil UK, Saraogi R.Patil UK, et al.Arch Dermatol Res. 2014 Jul;306(5):419-26. doi: 10.1007/s00403-014-1445-y. Epub 2014 Jan 31.Arch Dermatol Res. 2014.PMID:24481830Review.
- Ammonium carbamates as highly active transdermal permeation enhancers with a dual mechanism of action.Novotný M, Klimentová J, Janůšová B, Palát K, Hrabálek A, Vávrová K.Novotný M, et al.J Control Release. 2011 Mar 10;150(2):164-70. doi: 10.1016/j.jconrel.2010.11.017. Epub 2010 Nov 17.J Control Release. 2011.PMID:21093505
Cited by
- Flexible Monitoring, Diagnosis, and Therapy by Microneedles with Versatile Materials and Devices toward Multifunction Scope.Wang S, Zhao M, Yan Y, Li P, Huang W.Wang S, et al.Research (Wash D C). 2023 Apr 28;6:0128. doi: 10.34133/research.0128. eCollection 2023.Research (Wash D C). 2023.PMID:37223469Free PMC article.Review.
- Advancements in Skin-Mediated Drug Delivery: Mechanisms, Techniques, and Applications.Lee DH, Lim S, Kwak SS, Kim J.Lee DH, et al.Adv Healthc Mater. 2024 Mar;13(7):e2302375. doi: 10.1002/adhm.202302375. Epub 2023 Dec 7.Adv Healthc Mater. 2024.PMID:38009520Free PMC article.Review.
- Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.Lin W, Cormier M, Samiee A, Griffin A, Johnson B, Teng CL, Hardee GE, Daddona PE.Lin W, et al.Pharm Res. 2001 Dec;18(12):1789-93. doi: 10.1023/a:1013395102049.Pharm Res. 2001.PMID:11785702No abstract available.
- Solvent effects in permeation assessed in vivo by skin surface biopsy.Rosado C, Rodrigues LM.Rosado C, et al.BMC Dermatol. 2003 Dec 18;3:5. doi: 10.1186/1471-5945-3-5.BMC Dermatol. 2003.PMID:14680512Free PMC article.Clinical Trial.
- Investigating how the attributes of self-associated drug complexes influence the passive transport of molecules through biological membranes.Inacio R, Barlow D, Kong X, Keeble J, Jones SA.Inacio R, et al.Eur J Pharm Biopharm. 2016 May;102:214-22. doi: 10.1016/j.ejpb.2016.03.002. Epub 2016 Mar 8.Eur J Pharm Biopharm. 2016.PMID:26965142Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources